Scarica l'app Stockscreener
113.76
0.82%
0.92
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RVTY Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$112.84
Aprire:
$113.37
Volume 24 ore:
954.55K
Relative Volume:
0.69
Capitalizzazione di mercato:
$12.69B
Reddito:
$2.90B
Utile/perdita netta:
$239.11M
Rapporto P/E:
53.92
EPS:
2.1097
Flusso di cassa netto:
$492.62M
1 W Prestazione:
+0.20%
1M Prestazione:
+13.32%
6M Prestazione:
+15.90%
1 anno Prestazione:
+12.75%
Intervallo 1D:
$112.19
$114.50
Intervallo di 1 settimana:
$109.62
$116.16
Portata 52W:
$81.22
$118.30
Revvity Inc Stock (RVTY) Company Profile
Nome
Revvity Inc
Settore
Industria
Telefono
781-663-6900
Indirizzo
77 4TH AVENUE, WALTHAM
Compare RVTY vs TMO, DHR, IDXX, NTRA, WAT
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RVTY
Revvity Inc
|
113.76 | 12.41B | 2.90B | 239.11M | 492.62M | 2.1097 |
TMO
Thermo Fisher Scientific Inc
|
523.44 | 186.32B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
197.93 | 134.82B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
557.80 | 41.53B | 4.45B | 1.10B | 1.06B | 13.59 |
NTRA
Natera Inc
|
279.32 | 38.88B | 2.50B | -226.32M | 71.51M | -1.6412 |
WAT
Waters Corp
|
379.29 | 36.82B | 3.77B | 449.25M | 240.68M | 7.8556 |
Revvity Inc Stock (RVTY) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-14 | Downgrade | Barclays | Overweight → Equal Weight |
| 2025-12-15 | Downgrade | BofA Securities | Buy → Neutral |
| 2025-12-09 | Iniziato | Goldman | Neutral |
| 2025-10-16 | Iniziato | Guggenheim | Neutral |
| 2025-05-01 | Aggiornamento | UBS | Neutral → Buy |
| 2025-01-10 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2024-12-13 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-10-15 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2024-08-28 | Iniziato | Wells Fargo | Equal Weight |
| 2024-07-08 | Iniziato | Leerink Partners | Outperform |
| 2024-06-03 | Ripresa | Jefferies | Hold |
| 2024-01-16 | Downgrade | UBS | Buy → Neutral |
| 2024-01-04 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-12-19 | Iniziato | Wells Fargo | Equal Weight |
| 2023-12-13 | Iniziato | Wolfe Research | Peer Perform |
| 2023-09-28 | Iniziato | Bernstein | Outperform |
| 2023-07-19 | Iniziato | Raymond James | Outperform |
| 2023-05-23 | Ripresa | Goldman | Buy |
Mostra tutto
Revvity Inc Borsa (RVTY) Ultime notizie
Revvity Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Revvity, Inc. Expands Signals AI Ecosystem Through Anthropic Claude Integration - marketscreener.com
Revvity Expands Signals AI Ecosystem Through Anthropic Claude Integration - 01net
Revvity (RVTY) Enhances R&D Access through Partnership with Anth - GuruFocus
Revvity adds Signals connector to Anthropic’s Claude platform - Investing.com
Revvity adds Signals connector to Anthropic’s Claude platform By Investing.com - Investing.com Australia
Revvity lets scientists tap R&D data in Claude through new connector - Stock Titan
The EnLite Neonatal TREC kit from Revvity Inc.newborn screening focuses on severe immune defects - AD HOC NEWS
Revvity Inc. stock outperforms competitors despite losses on the day - MarketWatch
Revvity Q1 2026 Earnings: EPS Beats Estimates by 2.27% Amid Revenue DisclosuresEarnings Season Outlook - dars.gov.et
Signals AI boosts scientific R&D with agentic insights - Select Science
Revvity, Inc.(NYSE: RVTY) added to Russell 2500 Index - marketscreener.com
Revvity sets its post-Pandemic health strategy, shares on the NYSE in a diversified diagnostics peer - AD HOC NEWS
Revvity opens the weekend with strategy focus, shares on NYSE radar - AD HOC NEWS
Enterprise value to revenue forward of Revvity, Inc. – NYSE:RVTY - TradingView
REVVITY INC : BERNSTEIN RESUMES COVERAGE WITH MARKET-PERFORM RATING; PRICE TARGET $115 - Moomoo
Price to sales forward of Revvity, Inc. – NYSE:RVTY - TradingView
Revvity (RVTY) Coverage Initiated by Bernstein with $115 Target - GuruFocus
Price to earnings forward of Revvity, Inc. – NYSE:RVTY - TradingView
RVTY Reinstated by Bernstein -- Market Perform Rating Announced - GuruFocus
Bernstein Maintains Revvity(RVTY.US) With Hold Rating, Maintains Target Price $115 - Moomoo
Bernstein SocGen resumes Revvity stock coverage with Market Perform - Investing.com UK
RVTY Forecast — Price Target — Prediction for 2027 - TradingView
Revvity Inc. stock outperforms competitors on strong trading day - MSN
Revvity, Inc. Actuals & Estimates (NYSE:RVTY) - TradingView
Bernstein SocGen resumes Revvity stock coverage with Market Perform By Investing.com - Investing.com India
Revvity launches Signals AI to advance scientific R&D workflows - MSN
PKN Forecast — Price Target — Prediction for 2027 - TradingView
Revvity, Inc. Actuals & Estimates (DUS:PKN) - TradingView
Revvity plans second quarter earnings release, shares on NASDAQ in a crowded diagnostics peer group - AD HOC NEWS
Revvity Inc (RVTY) Shares Surge 7.5% -- What GF Score of 75 Tells Investors - GuruFocus
Revvity, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.0357143 Sh - TradingView
Revvity Rises as Investors Weigh New AI Launch and Earlier Q1 Strength - Moomoo
Revvity Jumps 6.8% Amid Sector-Wide Rally - AlphaStreet
Global Laboratory Equipment Services Market Size/Share Worth USD 62.83 Billion by 2035 at a 8% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - GlobeNewswire Inc.
How Revvity’s New Signals AI-Powered R&D Platform (RVTY) Has Changed Its Investment Story - simplywall.st
Barclays Maintains Revvity(RVTY.US) With Hold Rating, Maintains Target Price $105 - Moomoo
Revvity edges higher with a clear analyst consensus, shares backed by Buy ratings - AD HOC NEWS
Revvity Launches Signals AI to Advance Scientific R&D Workflows - Zacks Investment Research
Revvity Enhances AI Features in Signals Software (RVTY) - GuruFocus
Revvity focuses on biologics software strategy, shares trade quietly on the NYSE - AD HOC NEWS
Revvity Launches Signals AI, a Native Agentic Framework for Accelerating Scientific R&D - 01net
Revvity Expands Signals One Platform With New AI Capabilities for Scientific R&D - citybiz
Revvity Inc. (RVTY) Slides Slightly Amid Cautious Trading, Holds Above Key SupportIV Rank - dars.gov.et
Revvity Inc. Stockbackground snapshot on diagnostics and life science tools - AD HOC NEWS
Revvity StockWeekly review and sector context - AD HOC NEWS
Is Revvity Stock Underperforming the Nasdaq? - Barchart
Why Revvity’s Signals Image Artist software is becoming a quiet lab workhorse - AD HOC NEWS
Revvity Inc (RVTY) Valuation: PE, PB & Fair Value Analysis - TradingKey
Revvity Inc (RVTY) Institutional Confidence - TradingKey
Revvity Inc (RVTY) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Revvity Inc Azioni (RVTY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.14%
0.62%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):